Venture Investors

Founded 1982
Founders John Neis Roger Ganser

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 90
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 51
Rounds per year 2.31
Lead investments 30
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.46
Exits 18
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Therapeutics
Summary

In 1982 was created Venture Investors, which is appeared as VC. The leading representative office of defined VC is situated in the Madison. The venture was found in North America in United States.

The top amount of exits for fund were in 2016. The real fund results show that this VC is 35 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. This Venture Investors works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Venture Investors, startups are often financed by Wisconsin Alumni Research Foundation, Novartis Venture Fund, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Wisconsin Investment Partners, Novartis Venture Fund, Triathlon Medical Venture Partners. In the next rounds fund is usually obtained by Wisconsin Investment Partners, Wisconsin Alumni Research Foundation, Triathlon Medical Venture Partners.

The fund was created by John Neis, Roger Ganser. The overall number of key employees were 4.

Among the most popular portfolio startups of the fund, we may highlight Juventas Therapeutics, Alfalight, FluGen. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Manufacturing. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

EnsoData

Analytics
Artificial Intelligence
Health Care
Information Technology
Machine Learning
Software
$9M10 Jun 2020 Madison, Wisconsin, United States

HistoSonics

Health Care
Medical
Medical Device
Other Healthcare Technology Systems
Surgical Devices
$40M08 Jun 2020 Minnesota, United States

Eximis Surgical

Health Care
Hospital
Medical Device
$17M28 Feb 2020 Colorado, United States

Health Scholars

Health Care
Hospital
$17M16 Jan 2020 Westminster, Colorado, United States

SkySpecs

Aerospace
Analytics
Asset Management
Drones
Energy Efficiency
Productivity Tools
Renewable Energy
Robotics
Wind Energy
$17M21 Dec 2019 Ann Arbor, Michigan, United States

HistoSonics

Health Care
Medical
Medical Device
Other Healthcare Technology Systems
Surgical Devices
$54M08 Apr 2019 Minnesota, United States

Eximis Surgical

Health Care
Hospital
Medical Device
$7M08 Nov 2018 Colorado, United States

Invenra

Biotechnology
Life Science
Medical
Pharmaceutical
$7M17 Oct 2018 Madison, Wisconsin, United States

HealthMyne

Health Care
Hospital
Medical
$15M01 Aug 2018 Madison, Wisconsin, United States
News
Iterion Therapeutics Lands $17M Series B

– Iterion Therapeutics, a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, has raised $17m in a Series B financing.
РThe round was led by Lumira Ventures, with the participation of existing investors, including Sant̩ Ventures, as well as new investors Venture Investors, GPG Ventures, and Viva BioInnovator.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Venture Investors?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: